Objectives: The aim of this study was to determine preoperative risk factors associated with unplanned reoperation within 30 days for patients undergoing major surgery for primary ovarian cancer using the National Surgical Quality Improvement Program database. Methods: We conducted a retrospective cohort study utilizing the National Surgical Quality Improvement Program database to identify patients undergoing primary ovarian cancer surgery from 2012 to 2014. Patients who had a reoperation within 30 days of their primary surgery were identified. Demographics and clinical covariates were calculated. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using univariate and multivariate logistic regression approaches to assess the association. Results: A total of 4260 patients were identified during the study period. One hundred forty-eight patients (3.5%) underwent a reoperation within 30 days of their primary surgery. In univariate analysis, preoperative creatinine 1.5 mg/dL or greater (P = 0.010), smoking (P = 0.003), and both insulin-dependent (P = 0.029) and nonYinsulin-dependent diabetes mellitus (P = 0.048) were predictive of a reoperation. Multivariate analysis noted that smoking (OR, 1.94; 95% CI, 1.26Y2.99), insulin-dependent diabetes mellitus (OR, 2.18; 95% CI, 1.08Y4.40), nonYinsulin-dependent diabetes mellitus (OR, 1.65; 95% CI, 1.01Y2.72), and preoperative creatinine (OR, 2.65; 95% CI, 1.26Y5.58) were predictive of a reoperation. Age 50 to 60 years was protective against reoperation when compared with age younger than 50 years (OR, 0.54; 95% CI, 0.32Y0.90). Conclusions: Efforts to reduce reoperation rates should focus on identifying high-risk patients by utilizing objective preoperative data. Optimizing their medical status prior to surgery may decrease the reoperation rate in patients with ovarian cancer, thereby improving outcomes and providing a probable cost benefit.
T he need for surgical reoperation in close proximity to an initial operation carries a significant risk of severe morbidity and postoperative mortality. Although reoperation rates and resultant morbidity and mortality differ across specialties, patients who undergo the stress of a second operation universally have worse outcomes. 1Y4 In a large single-center study spanning all surgical specialties, reoperation carried a 21.9% risk of postoperative mortality. 1 Birkmeyer et al 3 demonstrated an overall reoperation rate of 3.5% in general surgery patients, with a disproportionate number of those cases coming from a small number of procedures, including 18.0% from colon resection. In 2013, Clark et al 5 noted that the reoperation rate for patients with stages IIYIV ovarian cancer undergoing a primary cytoreduction via laparotomy was comparable to that seen in the general surgery population at 5.2%.
There are substantial risks associated with reoperation across all surgical specialties, and given the significant contribution of reoperation to 30-day readmission rates, it is an important target for quality improvement. Multiple studies have evaluated causes as well as cost attributed to readmissions in gynecology oncology patients. In 2 single-center studies, cost for each readmission ranged from $8000 to $9300, whereas the main causes for readmission were infection, wound complications, and small bowel obstructions, all of which could necessitate reoperation. 6Y8 In a similar study, diabetes, obesity, smoking, renal comorbidities, and American Society of Anesthesiologists (ASA) class greater than 3 were identified as risk factors for surgical site infections in women undergoing hysterectomies, which are risk factors for readmission. 9 Identifying the factors associated with reoperation may allow for improved perioperative management of patients at the highest risk, thereby reducing the rate of reoperation, improving patient outcomes, and providing a cost benefit. The objective of this study was to determine preoperative factors associated with unplanned reoperation within 30 days in patients undergoing major surgery for primary ovarian cancer using the National Surgical Quality Improvement Program (NSQIP) database.
MATERIALS AND METHODS

Data Source and Patient Selection
The NSQIP database was used to identify all patients undergoing laparotomy for the primary treatment of ovarian cancer from January 2012 to December 2014. The NSQIP database is a large national database first validated by Khuri et al 10 
Variables and Outcomes
Baseline preoperative demographics and clinical characteristics were analyzed. The primary outcome was reoperation within 30 days of primary surgery. The following demographics and clinical covariates were identified as potential risk factors based on clinical experience as well as rationale from the existing literature: age, ASA class 3 or 4, race, tobacco use, preoperative hematocrit of less than 26%, preoperative creatinine of greater than 1.5 mg/dL, diabetes (insulin-dependent and nonYinsulin-dependent diabetes mellitus [IDDM and NIDDM]), and body mass index (BMI) of greater than 40 kg/m 2 .
Statistical Analysis
Frequencies and percentages were calculated for categorical variables. In order to assess differences in clinical covariates among patients undergoing reoperation within 30 days of primary operation, we estimated both unadjusted and adjusted odds ratios (ORs) and their corresponding 95% confidence intervals (95% CIs) using logistic regression analyses in order to prevent bias and potential confounders. Type III analysis of effect P values was calculated to examine overall categorical differences across covariates in the model. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC), where statistical significance was considered if P G 0.05.
RESULTS
Four thousand two hundred sixty patients underwent a laparotomy for primary treatment of ovarian cancer during the study period. Demographic information is depicted in Table 1 . One hundred forty-eight (3.5%) patients required reoperation within 30 days of their primary surgery. More than 55% of the patients were older than 60 years, with a mean age of 60.4 years. The mean preoperative albumin for all patients, regardless of the need for reoperation, was similar at 3.9 g/dL and thus not selected as a variable.
Both in our univariate and multivariate analyses, 3 major risk factors were isolated as independent risk factors of reoperation within 30 days: elevated preoperative creatinine (Q1.5 mg/dL), smoking (910 cigarettes per day), and diabetes (both IDDM and NIDDM) ( Tables 2 and 3 ). There was no association between reoperation and race, preoperative hematocrit, BMI, or ASA class. Increasing age was not a risk factor for reoperation; in fact, the risk of reoperation for patients aged 50 to 60 years was significantly lower than that for patients younger than 50 years (Table 3) .
There were several indications for reoperation, which are detailed in Table 4 . There were 189 indications for reoperation in the 148 patients requiring a reoperation as some patients had multiple indications for a reoperation. Ninety-two percent of the reoperations were at least in part due to bleeding or infection postoperatively. The most common indication for reoperation was bleeding (41.8%) requiring transfusion either intraoperatively or postoperatively. Both preoperative sepsis (4.2%) and postoperative sepsis (12.7%) were significant contributors to reoperation. Infection, which was stratified into superficial (6.3%), deep (7.4%), and organ space infection (19.6%), was also a common reason for reoperation.
DISCUSSION
The overall rate of reoperation after primary surgical treatment of ovarian cancer for patients in the NSQIP database from 2012 to 2014 was 3.5%, which is consistent with previous estimates in ovarian cancer and general surgery patients. 3 Using the NSQIP database, we identified 3 independent risk factors for unplanned reoperation within 30 days of initial surgery, which include preoperative creatinine of greater than 1.5 mg/dL, smoking more than 10 cigarettes a day, and both NIDDM and IDDM.
It has been well established that smoking worsens perioperative outcomes. This is in part due to altering migration and destruction of fibroblasts, which are important to healing. 11 In a 2011 study, Turan et al 12 examined postoperative patients and smoking within 30 days of primary surgery and found that smokers had increased deep and superficial infections, organ space infections, bleeding, septic shock, pulmonary embolism, and pneumonia. 12 More specifically, smoking was found to significantly increase anastomotic breakdown in patients healing from esophagogastric cancer, 13 which is a concern for gynecologic oncologists who routinely perform bowel surgery.
Similarly to smoking, diabetes has been established as a risk factor for poor healing because of its immunologic and vasculopathic effects.
14 Several factors prevent wound healing in diabetic patients including impaired macrophage function, a variety of growth factors, and decreased angiogenesis. Tissue biopsies have showed increased expression of c-myc and A-catenin, which inhibited proper wound healing in diabetic foot ulcers by a variety of mechanisms including fibroblast inactivation. 15, 16 Cancienne et al 17 found that hemoglobin A 1c values greater than 7.5% significantly increased infections after lumbar decompression surgery. Although hemoglobin A 1c would have been an excellent marker for both the presence of and severity of diabetes in our study, NSQIP did not collect this variable during the study time period. Nevertheless, poorly controlled diabetes clearly increases the chances of postoperative complications, including infection and sepsis, which were major causes of reoperation in this population. The impact of impaired renal function, as evidenced by increased baseline creatinine values, has also previously been evaluated. The use of insulin for diabetes and preoperative serum creatinine greater than 2.0 mg/dL have been independently associated with major cardiac complications during noncardiac surgery. 18 A subsequent meta-analysis confirmed the observation showing chronic kidney disease is a risk factor for death or cardiac event postoperatively. 19 Similarly, increases in preoperative creatinine were significantly associated with postoperative morbidity and mortality, which included infectious causes and significant bleeding. These risks were increased in postoperative patients based on creatinine of greater than 1.5 mg/dL and even more so for patients with a creatinine of greater than 3.0 mg/dL. 20 Canedo et al 21 found that patients with chronic kidney disease stage 3 or 4 undergoing colorectal surgery had a higher incidence of surgical site infection. The glomerular filtration rate the authors used to characterize these patients corresponds to a creatinine of 1.5, which is also used to predict major adverse cardiac events. 22 Lastly, older age was protective against reoperation in our population. Patients who were 50 to 60 years old were less likely to undergo reoperation when compared with patients younger than 50 years, and although not statistically significant, there was a similar trend in the 2 older age brackets. Interestingly, a study looking at patients undergoing pancreatic surgery also found younger age to be a risk factor. 4 It is logical to think surgeons are more likely to be aggressive in younger patients, which may lead to greater blood loss, longer surgery times, and more radical surgery to remove tumor. A more aggressive surgical approach may predispose younger patients to reoperation.
Our findings suggest that elevated creatinine, diabetes, and smoking, which are potentially modifiable risk factors, are significantly associated with reoperation in ovarian cancer patients undergoing primary cytoreduction. In this population, BMI, increased ASA class, race, and preoperative hematocrit were not associated with reoperation. There were some limitations to the study. First, we evaluated only patients who had a laparotomy; therefore, the data may not apply to patients undergoing minimally invasive surgery. Similarly, we did not evaluate other gynecologic malignancies besides ovarian, so these preoperative risk factors may not apply to the entire field of gynecologic oncology. In addition, it is difficult to determine if these patients had received neoadjuvant chemotherapy. Numerous studies have demonstrated a significant increase in postoperative adverse events and mortality in patients undergoing primary surgery compared with neoadjuvant chemotherapy, 17, 18 although neoadjuvant chemotherapy is considered to be a negative prognostic factor. Lastly, although we were able to stratify individuals with IDDM and NIDDM, we did not have data on hemoglobin A 1c levels.
In summary, efforts to reduce reoperation rates should focus on identifying high-risk patients by utilizing objective preoperative data isolated in this study. Although the presence of risk factors such as these should not be utilized solely to assign a patient to neoadjuvant chemotherapy rather than primary cytoreductive surgery, they warrant further study. Avoiding surgery or optimizing medical comorbidities in these high-risk patients prior to surgery may decrease the reoperation rate, therefore decreasing morbidity and mortality, as well as improving surgical outcomes. 
